Stock listing
Metavia Inc.
Selected listing: MTVA · NASDAQ · USD · US
Metavia Inc. (NASDAQ:MTVA), Health Technology. Latest release Sep 9, 2026: MetaVia Announces Preclinical Findings Supporting Biological Rationale…
- Ticker
- NASDAQ:MTVA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Metavia Inc.
The company focuses on its core business activities and aims to deliver value to its stakeholders. Investors can find relevant information about Metavia's performance and strategic direction on its public company page.
Latest news from Metavia Inc.
MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
September 9, 2026
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
July 9, 2026
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
June 8, 2026
MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
May 27, 2026